{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:39:22Z","timestamp":1778812762029,"version":"3.51.4"},"reference-count":96,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1517\/14712598.8.4.397","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T02:49:31Z","timestamp":1205981371000},"page":"397-407","source":"Crossref","is-referenced-by-count":26,"title":["Gene therapy of inherited immunodeficiencies"],"prefix":"10.1517","volume":"8","author":[{"given":"Giorgia","family":"Santilli","sequence":"first","affiliation":[{"name":"Senior Research Fellow University College London, Institute of Child Health, Centre for Immunodeficiency, Molecular Immunology Unit, 30 Guilford Street, London, WC1N 1EH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susannah I","family":"Thornhill","sequence":"additional","affiliation":[{"name":"Research Fellow University College London, Institute of Child Health, Centre for Immunodeficiency, Molecular Immunology Unit, 30 Guilford Street, London, WC1N 1EH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kinnon","sequence":"additional","affiliation":[{"name":"Professor of Molecular Immunology University College London, Institute of Child Health, Centre for Immunodeficiency, Molecular Immunology Unit, 30 Guilford Street, London, WC1N 1EH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J","family":"Thrasher","sequence":"additional","affiliation":[{"name":"Professor of Paediatric Immunology University College London, Institute of Child Health, Centre for Immunodeficiency, Molecular Immunology Unit, 30 Guilford Street, London, WC1N 1EH, UK"},{"name":"Great Ormond Street Hospital NHS Trust, Department of Clinical Immunology, London WC1N 3RJ, UK ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2008,3,19]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10245330500067249"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.2741\/967"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.10.8.4239-4242.1990"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00223.x"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90167-O"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/35040504"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200003)30:3<732::AID-IMMU732>3.0.CO;2-L"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/377065a0"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12513-5"},{"key":"e_1_3_1_12_1","first-page":"3646","volume":"91","author":"Haddad","year":"1998","unstructured":"Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646-53","journal-title":"Blood"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400703"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.274"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5466.669"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012616"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17590-9"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4837"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-058933"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.09.002"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.12.009"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115761"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5235.475"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2800"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5235.470"},{"key":"e_1_3_1_26_1","first-page":"179","volume":"3","author":"Hoogerbrugge","year":"1996","unstructured":"Hoogerbrugge PM, van BV, Fischer A, et al. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Gene Ther 1996;3:179-83","journal-title":"Gene Ther"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1095-1017"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0502-423"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1070104"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.06.007"},{"key":"e_1_3_1_31_1","unstructured":"Candotti F Kohn DB. Gene Therapy for adenosine deaminase deficiency in the USA. IVth Conference on Stem Cell Gene Therapy; 2007"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-031476"},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"Ariga T. Hematopoietic stem cell (HSC) gene therapy for two patients with adenosine deaminase (ADA) deficiency without cytoreductive conditioning; a suggestion for the optimal protocol for HSC gene therapy for ADA deficiency. IVth Conference on Stem Cell Gene Therapy; 2007","DOI":"10.1016\/j.bcmd.2007.10.013"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-023507"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.02.013"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90528-2"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.02.005"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20040176"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.02.007"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/85886"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062324"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300926"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/104303402753812449"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3489"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301950"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1423"},{"key":"e_1_3_1_47_1","first-page":"390","volume":"8","author":"Boztug","year":"2006","unstructured":"Boztug K, Dewey RA, Klein C. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr Opin Mol Ther 2006;8:390-5","journal-title":"Curr Opin Mol Ther"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.08.008"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.303"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302440"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302863"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5245"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151260498"},{"key":"e_1_3_1_54_1","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V85.9.2471.bloodjournal8592471","volume":"85","author":"Wengler","year":"1995","unstructured":"Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 1995;85:2471-7","journal-title":"Blood"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302457"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.2.181"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2003.12.001"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115653"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200005000-00003"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0583"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103223441203"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.231.bloodjournal851231"},{"key":"e_1_3_1_63_1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.7883\/yoken.JJID.2004.S27","volume":"57","author":"Malech","year":"2004","unstructured":"Malech HL, Choi U, Brenner S. Progress toward effective gene therapy for chronic granulomatous disease. Jpn J Infect Dis 2004;57:S27-8","journal-title":"Jpn J Infect Dis"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1393"},{"key":"e_1_3_1_65_1","doi-asserted-by":"crossref","unstructured":"European Society of Gene Therapy (ESGT). One of three successfully treated CGD patients in a Swiss-German gene therapy trial died due to his underlying disease: a position statement from the European Society of Gene Therapy (ESGT). J Gene Med 2006;8:1435","DOI":"10.1002\/jgm.991"},{"key":"e_1_3_1_66_1","unstructured":"Grez M Hoelzer D Ott MG. Gene therapy of chronic granulomatous disease: results and perspectives. 4th Annual Conference of British Society for Gene Therapy; 2007"},{"key":"e_1_3_1_67_1","unstructured":"Grez M Ott M Stein S et al. PhaseI\/II gene therapy study for X-CGD: results lessons and perspectives. IVth Conference on Stem Cell Gene Therapy; 2007"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200301163480314"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31659"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31661"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00864-4"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083413"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00760-8"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05219"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05218"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.10.4367"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404563"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1091667"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/4401123a"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1115"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1216"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603635103"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-024976"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608130103"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23966"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0782"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2032"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.10.3194"},{"key":"e_1_3_1_89_1","author":"Thornhill","year":"2008","unstructured":"Thornhill SI, Schambach A, Howe SJ, et al. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther 2008","journal-title":"Mol Ther"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5259.263"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1365"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302593"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.12.3926-3934.2001"},{"key":"e_1_3_1_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03556"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1352414"},{"key":"e_1_3_1_96_1","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood.V95.10.3078","volume":"95","author":"Davis","year":"2000","unstructured":"Davis BM, Koc ON, Gerson SL. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 2000;95:3078-84","journal-title":"Blood"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/2632"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00833.x"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.8.4.397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:15:53Z","timestamp":1770938153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.8.4.397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,19]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1517\/14712598.8.4.397"],"URL":"https:\/\/doi.org\/10.1517\/14712598.8.4.397","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,19]]}}}